The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antisense Therapy Market Research Report 2025
Synopsis
The global Antisense Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antisense Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antisense Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antisense Therapy in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antisense Therapy include Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, Dicerna Pharmaceuticals, Quark Pharmaceuticals, Benitec Biopharma and Sylentis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Therapy.
Report Scope
The Antisense Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antisense Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Ionis Pharmaceuticals, Inc.
Arbutus Biopharma (Tekmira)
Isarna Therapeutics
Arrowhead
Dicerna Pharmaceuticals
Quark Pharmaceuticals
Benitec Biopharma
Sylentis
Gradalis
Sarepta Therapeutics
Biogen
Segment by Type
RNA Antisense Therapy
DNA Antisense Therapy
Segment by Application
Cancer
Cardiovascular
HBV
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Antisense Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Antisense Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Antisense Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Antisense Therapy in Cancer is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Antisense Therapy include Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Inc., Arbutus Biopharma (Tekmira), Isarna Therapeutics, Arrowhead, Dicerna Pharmaceuticals, Quark Pharmaceuticals, Benitec Biopharma and Sylentis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Antisense Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antisense Therapy.
Report Scope
The Antisense Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antisense Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antisense Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alnylam Pharmaceuticals
Ionis Pharmaceuticals, Inc.
Arbutus Biopharma (Tekmira)
Isarna Therapeutics
Arrowhead
Dicerna Pharmaceuticals
Quark Pharmaceuticals
Benitec Biopharma
Sylentis
Gradalis
Sarepta Therapeutics
Biogen
Segment by Type
RNA Antisense Therapy
DNA Antisense Therapy
Segment by Application
Cancer
Cardiovascular
HBV
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antisense Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antisense Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 RNA Antisense Therapy
1.2.3 DNA Antisense Therapy
1.3 Market by Application
1.3.1 Global Antisense Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Cardiovascular
1.3.4 HBV
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antisense Therapy Market Perspective (2019-2030)
2.2 Antisense Therapy Growth Trends by Region
2.2.1 Global Antisense Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antisense Therapy Historic Market Size by Region (2019-2024)
2.2.3 Antisense Therapy Forecasted Market Size by Region (2025-2030)
2.3 Antisense Therapy Market Dynamics
2.3.1 Antisense Therapy Industry Trends
2.3.2 Antisense Therapy Market Drivers
2.3.3 Antisense Therapy Market Challenges
2.3.4 Antisense Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antisense Therapy Players by Revenue
3.1.1 Global Top Antisense Therapy Players by Revenue (2019-2024)
3.1.2 Global Antisense Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Antisense Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antisense Therapy Revenue
3.4 Global Antisense Therapy Market Concentration Ratio
3.4.1 Global Antisense Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antisense Therapy Revenue in 2023
3.5 Antisense Therapy Key Players Head office and Area Served
3.6 Key Players Antisense Therapy Product Solution and Service
3.7 Date of Enter into Antisense Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antisense Therapy Breakdown Data by Type
4.1 Global Antisense Therapy Historic Market Size by Type (2019-2024)
4.2 Global Antisense Therapy Forecasted Market Size by Type (2025-2030)
5 Antisense Therapy Breakdown Data by Application
5.1 Global Antisense Therapy Historic Market Size by Application (2019-2024)
5.2 Global Antisense Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antisense Therapy Market Size (2019-2030)
6.2 North America Antisense Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antisense Therapy Market Size by Country (2019-2024)
6.4 North America Antisense Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antisense Therapy Market Size (2019-2030)
7.2 Europe Antisense Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antisense Therapy Market Size by Country (2019-2024)
7.4 Europe Antisense Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antisense Therapy Market Size (2019-2030)
8.2 Asia-Pacific Antisense Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antisense Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Antisense Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antisense Therapy Market Size (2019-2030)
9.2 Latin America Antisense Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antisense Therapy Market Size by Country (2019-2024)
9.4 Latin America Antisense Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antisense Therapy Market Size (2019-2030)
10.2 Middle East & Africa Antisense Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antisense Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Antisense Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alnylam Pharmaceuticals
11.1.1 Alnylam Pharmaceuticals Company Detail
11.1.2 Alnylam Pharmaceuticals Business Overview
11.1.3 Alnylam Pharmaceuticals Antisense Therapy Introduction
11.1.4 Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2019-2024)
11.1.5 Alnylam Pharmaceuticals Recent Development
11.2 Ionis Pharmaceuticals, Inc.
11.2.1 Ionis Pharmaceuticals, Inc. Company Detail
11.2.2 Ionis Pharmaceuticals, Inc. Business Overview
11.2.3 Ionis Pharmaceuticals, Inc. Antisense Therapy Introduction
11.2.4 Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2019-2024)
11.2.5 Ionis Pharmaceuticals, Inc. Recent Development
11.3 Arbutus Biopharma (Tekmira)
11.3.1 Arbutus Biopharma (Tekmira) Company Detail
11.3.2 Arbutus Biopharma (Tekmira) Business Overview
11.3.3 Arbutus Biopharma (Tekmira) Antisense Therapy Introduction
11.3.4 Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2019-2024)
11.3.5 Arbutus Biopharma (Tekmira) Recent Development
11.4 Isarna Therapeutics
11.4.1 Isarna Therapeutics Company Detail
11.4.2 Isarna Therapeutics Business Overview
11.4.3 Isarna Therapeutics Antisense Therapy Introduction
11.4.4 Isarna Therapeutics Revenue in Antisense Therapy Business (2019-2024)
11.4.5 Isarna Therapeutics Recent Development
11.5 Arrowhead
11.5.1 Arrowhead Company Detail
11.5.2 Arrowhead Business Overview
11.5.3 Arrowhead Antisense Therapy Introduction
11.5.4 Arrowhead Revenue in Antisense Therapy Business (2019-2024)
11.5.5 Arrowhead Recent Development
11.6 Dicerna Pharmaceuticals
11.6.1 Dicerna Pharmaceuticals Company Detail
11.6.2 Dicerna Pharmaceuticals Business Overview
11.6.3 Dicerna Pharmaceuticals Antisense Therapy Introduction
11.6.4 Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2019-2024)
11.6.5 Dicerna Pharmaceuticals Recent Development
11.7 Quark Pharmaceuticals
11.7.1 Quark Pharmaceuticals Company Detail
11.7.2 Quark Pharmaceuticals Business Overview
11.7.3 Quark Pharmaceuticals Antisense Therapy Introduction
11.7.4 Quark Pharmaceuticals Revenue in Antisense Therapy Business (2019-2024)
11.7.5 Quark Pharmaceuticals Recent Development
11.8 Benitec Biopharma
11.8.1 Benitec Biopharma Company Detail
11.8.2 Benitec Biopharma Business Overview
11.8.3 Benitec Biopharma Antisense Therapy Introduction
11.8.4 Benitec Biopharma Revenue in Antisense Therapy Business (2019-2024)
11.8.5 Benitec Biopharma Recent Development
11.9 Sylentis
11.9.1 Sylentis Company Detail
11.9.2 Sylentis Business Overview
11.9.3 Sylentis Antisense Therapy Introduction
11.9.4 Sylentis Revenue in Antisense Therapy Business (2019-2024)
11.9.5 Sylentis Recent Development
11.10 Gradalis
11.10.1 Gradalis Company Detail
11.10.2 Gradalis Business Overview
11.10.3 Gradalis Antisense Therapy Introduction
11.10.4 Gradalis Revenue in Antisense Therapy Business (2019-2024)
11.10.5 Gradalis Recent Development
11.11 Sarepta Therapeutics
11.11.1 Sarepta Therapeutics Company Detail
11.11.2 Sarepta Therapeutics Business Overview
11.11.3 Sarepta Therapeutics Antisense Therapy Introduction
11.11.4 Sarepta Therapeutics Revenue in Antisense Therapy Business (2019-2024)
11.11.5 Sarepta Therapeutics Recent Development
11.12 Biogen
11.12.1 Biogen Company Detail
11.12.2 Biogen Business Overview
11.12.3 Biogen Antisense Therapy Introduction
11.12.4 Biogen Revenue in Antisense Therapy Business (2019-2024)
11.12.5 Biogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Antisense Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of RNA Antisense Therapy
Table 3. Key Players of DNA Antisense Therapy
Table 4. Global Antisense Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Antisense Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antisense Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antisense Therapy Market Share by Region (2019-2024)
Table 8. Global Antisense Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antisense Therapy Market Share by Region (2025-2030)
Table 10. Antisense Therapy Market Trends
Table 11. Antisense Therapy Market Drivers
Table 12. Antisense Therapy Market Challenges
Table 13. Antisense Therapy Market Restraints
Table 14. Global Antisense Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antisense Therapy Market Share by Players (2019-2024)
Table 16. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2023)
Table 17. Ranking of Global Top Antisense Therapy Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Antisense Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Antisense Therapy Product Solution and Service
Table 21. Date of Enter into Antisense Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antisense Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antisense Therapy Revenue Market Share by Type (2019-2024)
Table 25. Global Antisense Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antisense Therapy Revenue Market Share by Type (2025-2030)
Table 27. Global Antisense Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antisense Therapy Revenue Market Share by Application (2019-2024)
Table 29. Global Antisense Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antisense Therapy Revenue Market Share by Application (2025-2030)
Table 31. North America Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Antisense Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Antisense Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Antisense Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Antisense Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Antisense Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Antisense Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Antisense Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Antisense Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Antisense Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Antisense Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Antisense Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Antisense Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Alnylam Pharmaceuticals Company Detail
Table 47. Alnylam Pharmaceuticals Business Overview
Table 48. Alnylam Pharmaceuticals Antisense Therapy Product
Table 49. Alnylam Pharmaceuticals Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 50. Alnylam Pharmaceuticals Recent Development
Table 51. Ionis Pharmaceuticals, Inc. Company Detail
Table 52. Ionis Pharmaceuticals, Inc. Business Overview
Table 53. Ionis Pharmaceuticals, Inc. Antisense Therapy Product
Table 54. Ionis Pharmaceuticals, Inc. Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 55. Ionis Pharmaceuticals, Inc. Recent Development
Table 56. Arbutus Biopharma (Tekmira) Company Detail
Table 57. Arbutus Biopharma (Tekmira) Business Overview
Table 58. Arbutus Biopharma (Tekmira) Antisense Therapy Product
Table 59. Arbutus Biopharma (Tekmira) Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 60. Arbutus Biopharma (Tekmira) Recent Development
Table 61. Isarna Therapeutics Company Detail
Table 62. Isarna Therapeutics Business Overview
Table 63. Isarna Therapeutics Antisense Therapy Product
Table 64. Isarna Therapeutics Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 65. Isarna Therapeutics Recent Development
Table 66. Arrowhead Company Detail
Table 67. Arrowhead Business Overview
Table 68. Arrowhead Antisense Therapy Product
Table 69. Arrowhead Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 70. Arrowhead Recent Development
Table 71. Dicerna Pharmaceuticals Company Detail
Table 72. Dicerna Pharmaceuticals Business Overview
Table 73. Dicerna Pharmaceuticals Antisense Therapy Product
Table 74. Dicerna Pharmaceuticals Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 75. Dicerna Pharmaceuticals Recent Development
Table 76. Quark Pharmaceuticals Company Detail
Table 77. Quark Pharmaceuticals Business Overview
Table 78. Quark Pharmaceuticals Antisense Therapy Product
Table 79. Quark Pharmaceuticals Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 80. Quark Pharmaceuticals Recent Development
Table 81. Benitec Biopharma Company Detail
Table 82. Benitec Biopharma Business Overview
Table 83. Benitec Biopharma Antisense Therapy Product
Table 84. Benitec Biopharma Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 85. Benitec Biopharma Recent Development
Table 86. Sylentis Company Detail
Table 87. Sylentis Business Overview
Table 88. Sylentis Antisense Therapy Product
Table 89. Sylentis Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 90. Sylentis Recent Development
Table 91. Gradalis Company Detail
Table 92. Gradalis Business Overview
Table 93. Gradalis Antisense Therapy Product
Table 94. Gradalis Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 95. Gradalis Recent Development
Table 96. Sarepta Therapeutics Company Detail
Table 97. Sarepta Therapeutics Business Overview
Table 98. Sarepta Therapeutics Antisense Therapy Product
Table 99. Sarepta Therapeutics Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 100. Sarepta Therapeutics Recent Development
Table 101. Biogen Company Detail
Table 102. Biogen Business Overview
Table 103. Biogen Antisense Therapy Product
Table 104. Biogen Revenue in Antisense Therapy Business (2019-2024) & (US$ Million)
Table 105. Biogen Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antisense Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Antisense Therapy Market Share by Type: 2023 VS 2030
Figure 3. RNA Antisense Therapy Features
Figure 4. DNA Antisense Therapy Features
Figure 5. Global Antisense Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Antisense Therapy Market Share by Application: 2023 VS 2030
Figure 7. Cancer Case Studies
Figure 8. Cardiovascular Case Studies
Figure 9. HBV Case Studies
Figure 10. Other Case Studies
Figure 11. Antisense Therapy Report Years Considered
Figure 12. Global Antisense Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Antisense Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Antisense Therapy Market Share by Region: 2023 VS 2030
Figure 15. Global Antisense Therapy Market Share by Players in 2023
Figure 16. Global Top Antisense Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antisense Therapy as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Antisense Therapy Revenue in 2023
Figure 18. North America Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Antisense Therapy Market Share by Country (2019-2030)
Figure 20. United States Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Antisense Therapy Market Share by Country (2019-2030)
Figure 24. Germany Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Antisense Therapy Market Share by Region (2019-2030)
Figure 32. China Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Antisense Therapy Market Share by Country (2019-2030)
Figure 40. Mexico Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Antisense Therapy Market Share by Country (2019-2030)
Figure 44. Turkey Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Antisense Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Alnylam Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 47. Ionis Pharmaceuticals, Inc. Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 48. Arbutus Biopharma (Tekmira) Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 49. Isarna Therapeutics Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 50. Arrowhead Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 51. Dicerna Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 52. Quark Pharmaceuticals Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 53. Benitec Biopharma Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 54. Sylentis Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 55. Gradalis Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 56. Sarepta Therapeutics Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 57. Biogen Revenue Growth Rate in Antisense Therapy Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
